SCHEMBL7466167

SCHEMBL7466167

CCCc1[nH]c2cc(C(N)=O)ccc2c1C(=O)C1CC1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSK3B P49841 1/20 0.43
CCR3 P51677 2/20 0.40
CHEK2 O96017 2/20 0.40
CYP1A2 P05177 3/20 0.40
CYP2D6 P10635 2/20 0.40
HSD17B10 Q99714 2/20 0.40
CYP2C9 P11712 1/20 0.40
MPL P40238 2/20 0.39
MEN1 O00255 3/20 0.39
KMT2A Q03164 3/20 0.39
ATM Q13315 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
HTR1B P28222 4/20 0.39
HTR1A P08908 3/20 0.38
HTR1D P28221 2/20 0.38
PARP1 P09874 1/20 0.38
KDM4E B2RXH2 1/20 0.38
GAA P10253 1/20 0.38
ALDH1A1 P00352 1/20 0.38
CYP3A4 P08684 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7467838 0.95 CHEK2 (0.43) GSK3BCCR3CHEK2CYP1A2CYP2D6
SCHEMBL7422886 0.95 CHEK2 (0.46) GSK3BCCR3CHEK2CYP1A2CYP2D6
SCHEMBL7417074 0.94 CHEK2 (0.47) GSK3BCCR3CHEK2CYP1A2CYP2D6
SCHEMBL7467711 0.89 KDM4E (0.43) CCR3CYP1A2CYP2D6HSD17B10MPL
SCHEMBL7476488 0.86 KMT2A (0.57) GSK3BHSD17B10MEN1KMT2AATM
SCHEMBL27528020 0.85 CYP1A2 (0.43) CCR3CHEK2CYP1A2CYP2D6HSD17B10
SCHEMBL7471184 0.84 KDM4E (0.41) CCR3CYP1A2CYP2D6HSD17B10MPL
SCHEMBL7461131 0.84 KDM4E (0.41) CCR3HSD17B10MPLMEN1KMT2A
SCHEMBL7425271 0.83 SRD5A2 (0.43) CCR3CHEK2HSD17B10MPLMEN1
SCHEMBL7424222 0.81 HSD17B10 (0.43) CCR3CHEK2CYP1A2CYP2D6HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0820441-B1 INDOLE DERIVATIVES AS cGMP-PDE INHIBITORS FUJISAWA PHARMACEUTICAL CO (JP) 2002-06-26 EP disclosed
US-6358992-B1 Method of inhibiting neoplastic cells with indole derivatives CELL PATHWAYS, INC. 2002-03-19 US disclosed
US-6069156-A Indole derivatives as cGMP-PDE inhibitors FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2000-05-30 US disclosed